The Advisory Board Company (NASDAQ:ABCO) was downgraded by stock analysts at J P Morgan Chase & Co from an “overweight” rating to a “neutral” rating in a report issued on Friday. They currently have a $39.00 target price on the stock. J P Morgan Chase & Co’s price target suggests a potential downside of 17.46% from the stock’s current price. The analysts noted that the move was a valuation call.

ABCO has been the subject of several other research reports. Stifel Nicolaus reduced their target price on shares of The Advisory Board Company from $45.00 to $43.00 and set a “hold” rating for the company in a research note on Wednesday, November 2nd. Cantor Fitzgerald set a $37.00 target price on shares of The Advisory Board Company and gave the stock a “hold” rating in a research note on Wednesday, November 2nd. Canaccord Genuity lifted their target price on shares of The Advisory Board Company from $36.00 to $56.00 and gave the stock a “buy” rating in a research note on Thursday, February 9th. Piper Jaffray Companies downgraded shares of The Advisory Board Company from an “overweight” rating to a “neutral” rating and set a $42.00 target price for the company. in a research note on Friday, January 13th. They noted that the move was a valuation call. Finally, Zacks Investment Research upgraded shares of The Advisory Board Company from a “strong sell” rating to a “hold” rating in a research note on Monday, February 6th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and nine have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $44.06.

Analyst Recommendations for The Advisory Board Company (NASDAQ:ABCO)

Shares of The Advisory Board Company (NASDAQ:ABCO) traded down 2.12% during trading on Friday, reaching $46.25. 162,297 shares of the company traded hands. The Advisory Board Company has a 12-month low of $18.87 and a 12-month high of $51.23. The stock’s market capitalization is $1.86 billion. The firm’s 50-day moving average is $42.20 and its 200-day moving average is $40.05.

This piece of content was first reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another publication, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The original version of this piece of content can be viewed at http://www.dailypolitical.com/2017/02/17/the-advisory-board-company-abco-cut-to-neutral-at-j-p-morgan-chase-co.html.

In other The Advisory Board Company news, insider Hoose Mary Van sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, December 19th. The shares were sold at an average price of $32.48, for a total value of $64,960.00. Following the completion of the transaction, the insider now owns 37,386 shares of the company’s stock, valued at approximately $1,214,297.28. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Robert W. Musslewhite sold 5,500 shares of the business’s stock in a transaction that occurred on Monday, December 12th. The stock was sold at an average price of $33.87, for a total transaction of $186,285.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 32,884 shares of company stock valued at $1,262,106. 2.90% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in the company. Quantbot Technologies LP bought a new position in The Advisory Board Company during the third quarter worth approximately $110,000. BlackRock Japan Co. Ltd boosted its position in The Advisory Board Company by 102.7% in the third quarter. BlackRock Japan Co. Ltd now owns 2,820 shares of the company’s stock worth $126,000 after buying an additional 1,429 shares in the last quarter. Huntington National Bank boosted its position in The Advisory Board Company by 4.9% in the third quarter. Huntington National Bank now owns 4,660 shares of the company’s stock worth $208,000 after buying an additional 217 shares in the last quarter. Nwam LLC bought a new position in The Advisory Board Company during the third quarter worth approximately $209,000. Finally, Aperio Group LLC bought a new position in The Advisory Board Company during the third quarter worth approximately $212,000.

The Advisory Board Company Company Profile

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.

5 Day Chart for NASDAQ:ABCO

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.